• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

弥漫性正常血脂性扁平黄瘤病。异常的补体成分谱。

Diffuse normolipaemic plane xanthomatosis. An abnormal complement component profile.

作者信息

Jordon R E, McDuffie F C, Good R A, Day N K

出版信息

Clin Exp Immunol. 1974 Nov;18(3):407-15.

PMID:4219909
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1537989/
Abstract

A patient with diffuse normolipaemic plane xanthomatosis, a benign monoclonal gammopathy, and a low total serum complement level is described. Functional haemolytic assays revealed decreased levels of C1, C4 and C2 components and elevated levels of the two terminal components C8 and C9. Radial immunodiffusion demonstrated low levels of C1q and C4 and a high level of C3. Both functional and immunochemical studies revealed extremely low levels of the inhibitor of C1 esterase. Anticomplementary activity was not present in the patient's serum. Despite low concentrations of the early reacting components of the classic complement pathway, the alternate pathway seemed to be intact. It was concluded that the patient had the recently delineated syndrome of acquired deficiency of the C1-esterase inhibitor.

摘要

本文描述了一名患有弥漫性正常血脂性扁平黄瘤病、良性单克隆丙种球蛋白病且血清总补体水平较低的患者。功能性溶血试验显示C1、C4和C2成分水平降低,而两个终末成分C8和C9水平升高。放射免疫扩散法显示C1q和C4水平较低,C3水平较高。功能性和免疫化学研究均显示C1酯酶抑制剂水平极低。患者血清中不存在抗补体活性。尽管经典补体途径早期反应成分浓度较低,但替代途径似乎完好无损。结论是该患者患有最近明确的获得性C1酯酶抑制剂缺乏综合征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6e5/1537989/5e1facf2dc67/clinexpimmunol00268-0113-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6e5/1537989/5e1facf2dc67/clinexpimmunol00268-0113-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6e5/1537989/5e1facf2dc67/clinexpimmunol00268-0113-a.jpg

相似文献

1
Diffuse normolipaemic plane xanthomatosis. An abnormal complement component profile.弥漫性正常血脂性扁平黄瘤病。异常的补体成分谱。
Clin Exp Immunol. 1974 Nov;18(3):407-15.
2
[Complement system in glomerulonephritis. II. Detailed aspects].[肾小球肾炎中的补体系统。II. 详细方面]
Pediatr Pol. 1980 Jun;55(6):805-11.
3
Developmental aspects of complement components in the newborn. The presence of complement components and C3 proactivator (properdin factor B) in human colostrum.新生儿补体成分的发育情况。人初乳中补体成分及C3前活化剂(备解素因子B)的存在。
Clin Exp Immunol. 1974 Oct;18(2):257-66.
4
[Genetic deficiency of complement (author's transl)].补体的遗传性缺陷(作者译)
Nouv Presse Med. 1978 Nov 4;7(38):3443-7.
5
Complement function and disorders.补体功能与疾病
Pediatr Ann. 1976 Jun;5(6):397-404.
6
A case of diffuse plane xanthomatosis.一例弥漫性平面黄瘤病。
J Dermatol. 1980 Aug;7(4):247-54. doi: 10.1111/j.1346-8138.1980.tb01965.x.
7
C3 metabolism in a patient with deficiency of the second component of complement (C2) and discoid lupus erythematosus.一名补体第二成分(C2)缺乏且患有盘状红斑狼疮患者的C3代谢
Clin Exp Immunol. 1976 May;24(2):238-48.
8
[Angioneurotic hereditary edema. 3 faimilial cases].
Nouv Presse Med. 1976 Apr 3;5(14):911-4.
9
[Complement component deficiency and autoimmune diseases].
Harefuah. 1988 Sep;115(5-6):129-34.
10
[Acquired C1-esterase inhibitor deficiencies during lymphoid syndromes].[淋巴系统综合征期间获得性C1酯酶抑制剂缺乏症]
Nouv Presse Med. 1975 Nov 8;4(38):2705-8.

引用本文的文献

1
Diffuse normolipemic plane xanthoma associated with monoclonal gammopathy.与单克隆丙种球蛋白病相关的弥漫性正常血脂平面性黄瘤。
Dermatol Pract Concept. 2015 Oct 31;5(4):65-7. doi: 10.5826/dpc.0504a16. eCollection 2015 Oct.
2
Fast liver catabolism of C1q in patients with paraproteinaemia and depletion of the classical pathway of complement.副蛋白血症患者中C1q的肝脏快速分解代谢以及补体经典途径的耗竭。
Clin Exp Immunol. 1987 Jul;69(1):188-97.
3
Acquired c1-inhibitor deficiencies in lymphoproliferative diseases with serum immunoglobulin abnormalities. A study of three cases.

本文引用的文献

1
ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT.从人血清中分离β-免疫球蛋白并将其鉴定为补体的第五成分。
J Exp Med. 1965 Aug 1;122(2):277-98. doi: 10.1084/jem.122.2.277.
2
IMMUNOLOGICAL STUDIES OF THE 11S PROTEIN COMPONENT OF THE HUMAN COMPLEMENT SYSTEM.人类补体系统11S蛋白成分的免疫学研究。
J Exp Med. 1964 Feb 1;119(2):195-209. doi: 10.1084/jem.119.2.195.
3
ISOLATION AND DESCRIPTION OF THE FOURTH COMPONENT OF HUMAN COMPLEMENT.人补体第四成分的分离与描述
伴有血清免疫球蛋白异常的淋巴增生性疾病中的获得性C1抑制物缺乏症。三例病例研究。
Blut. 1976 Mar;32(3):195-206. doi: 10.1007/BF00995913.
4
Classical pathway complement activation in association with paraproteinaemia.经典途径补体激活与副蛋白血症相关
Immunology. 1977 Oct;33(4):517-21.
5
Acquired C1 inhibitor deficiency in a case of lymphosarcoma of the spleen. Reversal of complement abnormalities after splenectomy.脾淋巴瘤病例中的获得性C1抑制物缺乏。脾切除术后补体异常的逆转。
Clin Exp Immunol. 1979 Sep;37(3):523-31.
J Exp Med. 1963 Sep 1;118(3):447-66. doi: 10.1084/jem.118.3.447.
4
Diffuse normolipemic plane xanthoma. Generalized xanthelasma.弥漫性正常血脂性扁平黄瘤。泛发性睑黄瘤。
Arch Dermatol. 1962 May;85:633-40. doi: 10.1001/archderm.1962.01590050063012.
5
Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum.豚鼠血清中溶血补体九种成分的分离、纯化及测定方法
Immunochemistry. 1966 Mar;3(2):111-35. doi: 10.1016/0019-2791(66)90292-8.
6
Generalized plane xanthoma and systemic disease.泛发性平面型黄瘤与系统性疾病。
Arch Dermatol. 1966 Jun;93(6):639-46.
7
Xanthomatosis in cryoglobulinaemia and other paraproteinaemias with report of a case.
Br J Dermatol. 1968 Nov;80(11):719-29. doi: 10.1111/j.1365-2133.1968.tb11933.x.
8
The separation of nine components and two inactivators of components of complement in humansserum.人血清中补体九个成分及两个补体成分灭活剂的分离
Immunochemistry. 1970 Jan;7(1):43-61. doi: 10.1016/0019-2791(70)90029-7.
9
Activation of complement by a monoclonal cryoglobulin associated with cold urticaria.与冷性荨麻疹相关的单克隆冷球蛋白激活补体。
J Lab Clin Med. 1969 Dec;74(6):902-10.
10
The stoichiometric measurement of the serum inhibition of the first component of complement by the inhibition of immune hemolysis.通过免疫溶血抑制来进行血清对补体第一成分抑制作用的化学计量测量。
J Immunol. 1968 Jun;100(6):1154-64.